Rectosigmoid Mesorectal-Sparing Resection in Advanced Ovarian Cancer Surgery
Andrea Rosati(Agostino Gemelli University Polyclinic), Barbara Costantini(Università Cattolica del Sacro Cuore), Virginia Vargiu(Università Cattolica del Sacro Cuore), Claudio Lodoli(Agostino Gemelli University Polyclinic), Miriam Attalla El Halabieh(Agostino Gemelli University Polyclinic), Francesco Santullo(Agostino Gemelli University Polyclinic), Anna Fagotti(Agostino Gemelli University Polyclinic), Giovanni Scambia(Agostino Gemelli University Polyclinic)
Cited by 14
Related Papers
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2021|412
Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta‐analysis
|Ultrasound in Obstetrics and Gynecology|2017|299
SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer
|International Journal of Gynecological Cancer|2020|298
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
|Annals of Oncology|2024|277
Uterine serous carcinoma
|Gynecologic Oncology|2021|158